HonCode

Go Back   HER2 Support Group Forums > Articles of Interest
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Display Modes
Old 08-22-2021, 09:32 AM   #1
Nguyen
Senior Member
 
Join Date: Nov 2005
Posts: 349
Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase

This is one of our possible next regimen until I read the entire article below. She has Pi3K mutation but also ESR1 mutation at Y537S. Still nothing is certain in MBC, only toxicity side effects are. Do we risk certain toxicity (particularly in light of covid raging) for a chance of it might still work?

Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors

https://www.nature.com/articles/s43018-020-0047-1
Nguyen is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump


All times are GMT -7. The time now is 06:22 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2021, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter